Hubei, China
Business Type:
Manufacturer/Factory
Business Range:
Agriculture & Food, Chemicals, Health & Medicine, Sporting Goods & Recreation
Management System Certification:
ISO 9001, GMP
Export Year:
2016-10-09
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, ...
OEM/ODM Service
Sample Available

Deferasirox, Deferasirox Powders, Deferasirox Supplier manufacturer / supplier in China, offering Secondary Hemochromatosis Pharmaceutical Dfs CAS 201530-41-8 Deferasirox, China Recommend Antiglaucoma Agent CAS 155206-00-1 Bimatoprost, China Recommend Male Hair Loss API CAS 866460-33-5 Setipiprant and so on.

Gold Member Since 2016

Secondary Hemochromatosis Pharmaceutical Dfs CAS 201530-41-8 Deferasirox

Get Latest Price
Min. Order / Reference FOB Price
10 g US $1/ g
Port: Shenzhen, China
Production Capacity: 5000kg/Month
Payment Terms: T/T, Western Union, Money Gram, Bitcoin
Powder: Yes
Customized: Non-Customized
Certification: USP, BP, Research
Suitable for: Elderly, Adult
State: Powder
Purity: >99%

You Might Also Like

Loading...

Basic Info

Model NO.: 201530-41-8
Alias: Deferasirox 
Delivery: 3-5 Days 100%Door to Door
Appearance: White Crystalline Powder
Policy: Re-Shipping Policy
Shipment: EMS, FedEx, TNT, DHL, UPS
Payment: Western Union, Moneygram, T/T, Bitcoin
Trademark: WHSO
Transport Package: 25kg/Drum
Specification: 1kg/25kg/package
Origin: China
HS Code: 293729002

Product Description

Secondary Hemochromatosis Pharmaceutical Raw Materials DFS CAS 201530-41-8 Deferasirox


Product Name: Deferasirox 
Synonyms: 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid;deferasirox;Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-;Deferasirox for research;4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic Acid;CGP-72670;Exjade;ICL-670 
CAS: 201530-41-8 
MF: C21H15N3O4
MW: 373.3615
Product Categories: Chelating agent (iron);Aromatics Compounds;Aromatics;Chelating Agents & Ligands;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Pharmaceutical intermediate;Exjade, ICL-670, ICL-670A, CGP-72670
Melting point  260-262ºC 
Storage temp.  -20°C Freezer
Chemical Properties White to Off-White Solid 
Usage Orally active tridentate iron chelator 
Usage Biological Activity Chemical Information Tech Support & FAQs Biological Activity Deferasirox(Exjade) is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions 
Usage A tridentate chelator that binds iron with high affinity .
Usage Labeled Deferasirox, intended for use as an internal standard for the quantification of Deferasirox by GC- or LC-mass spectrometry. 


Deferasirox Overview

Deferasirox: chemical name 4- [3,5-bis (2-hydroxyphenyl) -1,2,4-triazol-1-yl] benzoic acid, is a kind of iron chelator products studied and developed by the Novartis company (Swiss). It was the first routinely used oral iron agent approved by US FDA, allowed to be applied for the treatment of iron overloading caused by blood transfusion in patients (older than 2 years old) of chronic anemia. In Europe, it is recommended as the first-line treatment drug for patients older than 6-year-old who are suffering blood iron overload patients. In China, it is currently subject to clinical research; 2, 3 clinical trials and pharmacokinetic studies have all shown that it has excellent safety and tolerability, and can significantly reduce the heart, liver iron load, easy to be accepted by the patient. At the same time, it also has pharmacological properties of antifungal (such as Mucor which can grow in iron-ricking environment), anti-cell proliferation, anti-malaria, antioxidant stress injury and anti-cytotoxicity induced apoptosis; it can be used for the treatment of hemochromatosis, delayed skin porphyria and other diseases. 


Deferasirox Uses 

1. DFS can be used to treat the reversible renal insufficiency caused by Fanconi syndrome.
2. It can be used for the treatment of secondary hemochromatosis.
3. It can be used for the treatment of delayed skin porphyria.
4. It can be used for the treatment of myelodysplastic syndromes.
5. It can be used for the treatment of iron overloading caused by blood transfusion for patients (older than 2 years old) of chronic anemia .



 
More products you may like
 
Sulbutiamine CAS 3286-46-2
Aniracetam CAS 72432-10-1
Noopept CAS 157115-85-0
Idra-21 CAS 22503-72-6
4-Aminobutyric acid CAS 56-12-2
NSI-189 Free Base CAS 1270138-40-3
NSI-189 Phosphate CAS 1270138-41-4
9-fluorenol CAS 1689-64-1
Coluracetam CAS 135463-81-9
Sunifiram CAS 314728-85-3
Pramiracetam CAS 68497-62-1
Piracetam CAS 7491-74-9
Oxiracetam CAS 62613-82-5
Fasoracetam CAS 110958-19-5
Nefiracetam CAS 77191-36-7
Centrophenoxine CAS 3685-84-5
Pikamilon Sodium CAS 62936-56-5
PRL-8-53 HCL CAS : 51352-87-5
 
Levodopa(L-DOPA) CAS : 59-92-7
Etiracetam(UCB-6474) CAS : 33996-58-6

Send your message to this supplier

*From:
*To:
avatar Mr. Eric(WAPP:+8617327093119)
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now